Literature DB >> 33923159

Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study.

Claudio Zanettini1, Mohamed Omar1, Wikum Dinalankara1, Eddie Luidy Imada1, Elizabeth Colantuoni2, Giovanni Parmigiani3,4, Luigi Marchionni1.   

Abstract

The COVID-19 mortality rate is higher in the elderly and in those with pre-existing chronic medical conditions. The elderly also suffer from increased morbidity and mortality from seasonal influenza infections; thus, an annual influenza vaccination is recommended for them. In this study, we explore a possible county-level association between influenza vaccination coverage in people aged 65 years and older and the number of deaths from COVID-19. To this end, we used COVID-19 data up to 14 December 2020 and US population health data at the county level. We fit quasi-Poisson regression models using influenza vaccination coverage in the elderly population as the independent variable and the COVID-19 mortality rate as the outcome variable. We adjusted for an array of potential confounders using different propensity score regression methods. Results show that, on the county level, influenza vaccination coverage in the elderly population is negatively associated with mortality from COVID-19, using different methodologies for confounding adjustment. These findings point to the need for studying the relationship between influenza vaccination and COVID-19 mortality at the individual level to investigate any underlying biological mechanisms.

Entities:  

Keywords:  COVID-19; influenza; influenza vaccine; mortality; vaccination coverage

Year:  2021        PMID: 33923159     DOI: 10.3390/vaccines9050427

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  43 in total

1.  Inhibition of human natural killer cell activity by influenza virions and hemagglutinin.

Authors:  Huawei Mao; Wenwei Tu; Yinping Liu; Gang Qin; Jian Zheng; Ping-Lung Chan; Kwok-Tai Lam; J S Malik Peiris; Yu-Lung Lau
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

2.  Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season.

Authors:  Greg G Wolff
Journal:  Vaccine       Date:  2019-10-10       Impact factor: 3.641

3.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.

Authors:  Jerome R Lechien; Carlos M Chiesa-Estomba; Daniele R De Siati; Mihaela Horoi; Serge D Le Bon; Alexandra Rodriguez; Didier Dequanter; Serge Blecic; Fahd El Afia; Lea Distinguin; Younes Chekkoury-Idrissi; Stéphane Hans; Irene Lopez Delgado; Christian Calvo-Henriquez; Philippe Lavigne; Chiara Falanga; Maria Rosaria Barillari; Giovanni Cammaroto; Mohamad Khalife; Pierre Leich; Christel Souchay; Camelia Rossi; Fabrice Journe; Julien Hsieh; Myriam Edjlali; Robert Carlier; Laurence Ris; Andrea Lovato; Cosimo De Filippis; Frederique Coppee; Nicolas Fakhry; Tareck Ayad; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-06       Impact factor: 2.503

4.  Hyperinflammatory shock in children during COVID-19 pandemic.

Authors:  Shelley Riphagen; Xabier Gomez; Carmen Gonzalez-Martinez; Nick Wilkinson; Paraskevi Theocharis
Journal:  Lancet       Date:  2020-05-07       Impact factor: 79.321

5.  Demographic perspectives on the mortality of COVID-19 and other epidemics.

Authors:  Joshua R Goldstein; Ronald D Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-20       Impact factor: 11.205

6.  Impact of the influenza vaccine on COVID-19 infection rates and severity.

Authors:  Anna Conlon; Carmel Ashur; Laraine Washer; Kim A Eagle; Marion A Hofmann Bowman
Journal:  Am J Infect Control       Date:  2021-02-22       Impact factor: 2.918

7.  Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil.

Authors:  Günther Fink; Nina Orlova-Fink; Tobias Schindler; Sandra Grisi; Ana Paula S Ferrer; Claudia Daubenberger; Alexandra Brentani
Journal:  BMJ Evid Based Med       Date:  2020-12-11

Review 8.  The immune response to influenza in older humans: beyond immune senescence.

Authors:  Janet E McElhaney; Chris P Verschoor; Melissa K Andrew; Laura Haynes; George A Kuchel; Graham Pawelec
Journal:  Immun Ageing       Date:  2020-05-07       Impact factor: 6.400

9.  Is COVID-19 receiving ADE from other coronaviruses?

Authors:  Jason A Tetro
Journal:  Microbes Infect       Date:  2020-02-22       Impact factor: 2.700

10.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

View more
  24 in total

1.  Impact of stringent non-pharmaceutical interventions applied during the second and third COVID-19 epidemic waves in Portugal, 9 November 2020 to 10 February 2021: an ecological study.

Authors:  Ana Rita Torres; Ana Paula Rodrigues; Mafalda Sousa-Uva; Irina Kislaya; Susana Silva; Liliana Antunes; Carlos Dias; Baltazar Nunes
Journal:  Euro Surveill       Date:  2022-06

2.  Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital.

Authors:  Roberta Pastorino; Leonardo Villani; Daniele Ignazio La Milia; Roberto Ieraci; Francesco Chini; Enrico Volpe; Alessandra Barca; Danilo Fusco; Patrizia Laurenti; Walter Ricciardi; Stefania Boccia
Journal:  Vaccine       Date:  2021-05-09       Impact factor: 3.641

3.  Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland.

Authors:  Małgorzata Kowalska; Ewa Niewiadomska; Kamil Barański; Angelina Kaleta-Pilarska; Grzegorz Brożek; Jan Eugeniusz Zejda
Journal:  Vaccines (Basel)       Date:  2021-04-21

4.  Perception, knowledge and attitude towards influenza vaccine during COVID-19 pandemic in Jordanian population.

Authors:  Waleed A Zalloum; Eman R Elayeh; Basel Al Haj Ali; Needa Zalloum
Journal:  Eur J Integr Med       Date:  2022-01-08       Impact factor: 1.314

Review 5.  Promising Expectations for Pneumococcal Vaccination during COVID-19.

Authors:  Hyobin Im; Jinhui Ser; Uk Sim; Hoonsung Cho
Journal:  Vaccines (Basel)       Date:  2021-12-20

6.  Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination.

Authors:  Vincenzo Puro; Concetta Castilletti; Chiara Agrati; Delia Goletti; Sara Leone; Alessandro Agresta; Eleonora Cimini; Eleonora Tartaglia; Rita Casetti; Francesca Colavita; Silvia Meschi; Giulia Matusali; Daniele Lapa; Saeid Najafi Fard; Alessandra Aiello; Chiara Farrone; Paola Gallì; Maria Rosaria Capobianchi; Giuseppe Ippolito
Journal:  Vaccines (Basel)       Date:  2021-06-08

7.  Response to "Potential for bias in assessing risk and protective factors for COVID-19: Commentary on Conlon et al.'s 'Impact of the influenza vaccination on COVID-19 infection rates and Severity'".

Authors:  Anna Conlon; Carmel Ashur; Laraine Washer; Kim A Eagle; Marion A Hofmann Bowman
Journal:  Am J Infect Control       Date:  2021-08       Impact factor: 2.918

8.  Effects of Influenza Vaccination on the Response to BNT162b2 Messenger RNA COVID-19 Vaccine in Healthcare Workers.

Authors:  Marilena Greco; Federico Cucci; Pierfrancesco Portulano; Roberta Assunta Lazzari; Cosimo Caldararo; Fernando Sicuro; Carmelo Catanese; Giambattista Lobreglio
Journal:  J Clin Med Res       Date:  2021-12-28

9.  The Potential Benefits of the Influenza Vaccination on COVID-19 Mortality Rate-A Retrospective Analysis of Patients in Poland.

Authors:  Kinga Izabela Stańczak-Mrozek; Adam Sobczak; Leszek Lipiński; Elżbieta Sienkiewicz; Dorota Makarewicz; Roman Topór-Mądry; Jarosław Pinkas; Radosław Adam Sierpiński
Journal:  Vaccines (Basel)       Date:  2021-12-21

10.  Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.

Authors:  Salka Enners; Gabriele Gradl; Marita Kieble; Michael Böhm; Ulrich Laufs; Martin Schulz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2021-07-21       Impact factor: 2.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.